Alcresta Therapeutics

Alcresta Therapeutics develops enzyme-based products designed to help people who have trouble digesting and absorbing the fats in their food. Its focus sits at the intersection of clinical nutrition and gastroenterology, addressing fat malabsorption in patients whose bodies cannot produce or deliver enough of the lipase needed to break down dietary fats — a common challenge in conditions like exocrine pancreatic insufficiency and among tube-fed patients.

What makes the company's approach distinctive is its use of an immobilized lipase cartridge technology that works with enteral (tube) feeding. Rather than relying solely on oral enzyme capsules, the enzyme is positioned in-line so that fats are broken down as the formula passes through, before it ever reaches the patient. For caregivers and clinicians managing patients on feeding tubes, this can mean better absorption of essential fatty acids and improved tolerance of standard formulas.

Buyers coming to this brand are typically clinical dietitians, home enteral nutrition patients and their families, or facility purchasers who already know they need enzymatic support for fat digestion. The key questions tend to be practical: which product suits an infant versus an adult, how it integrates with an existing pump-fed or gravity feeding setup, and how it fits into a broader nutrition plan overseen by a care team. Because these are specialized therapeutic products, it's worth confirming compatibility with your prescribed formula and feeding schedule before ordering.

Explore this collection to see the Alcresta products carried, and browse related specialty manufacturers such as Intensive Therapeutics, Choice Therapeutics, and Heron Therapeutics for adjacent therapeutic categories.